Table of Content

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview
4.1. Introduction
4.2. Topical Hemostat Market, by Region

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising numbers of surgeries due to an aging population and prevalence of chronic diseases
5.1.1.2. Favorable product approval by medical regulators
5.1.2. Restraints
5.1.2.1. High costs associated with topical hemostat products
5.1.3. Opportunities
5.1.3.1. Ongoing R&D for the introduction of novel topical hemostat
5.1.3.2. Integration of nanotechnology to create more efficient topical hemostats
5.1.4. Challenges
5.1.4.1. Operational limitations and risk of infection associated with the use of topical hemostats
5.2. Market Segmentation Analysis
5.2.1. Product: Burgeoning adoption of combination topical hemostats owing to the additional benefits such as infection reduction
5.2.2. Formulation: Proliferating utilization of matrix and gel hemostats owing to their ability to conform to irregular wound surfaces
5.2.3. Application: Significant usage of topical hemostats in cardiovascular surgery
5.2.4. End-Use: Evolving utilization of topical hemostats in hospitals
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework

6. Topical Hemostat Market, by Product
6.1. Introduction
6.2. Collagen-Based Topical Hemostats
6.3. Combination Topical Hemostats
6.4. Gelatin-Based Topical Hemostats
6.5. Oxidized Regenerated Cellulose-based Topical Hemostats
6.6. Thrombin-Based Topical Hemostats

7. Topical Hemostat Market, by Formulation
7.1. Introduction
7.2. Matrix & Gel Hemostats
7.3. Powder Hemostats
7.4. Sheet & Pad Hemostats
7.5. Sponge Hemostats

8. Topical Hemostat Market, by Application
8.1. Introduction
8.2. Cardiovascular Surgery
8.3. General Surgery
8.4. Liver & Spleen Lacerations
8.5. Orthopedic Surgery
8.6. Reconstructive Surgery

9. Topical Hemostat Market, by End-Use
9.1. Introduction
9.2. Hospitals
9.3. Nursing Homes
9.4. Surgical Centers

10. Americas Topical Hemostat Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States

11. Asia-Pacific Topical Hemostat Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam

12. Europe, Middle East & Africa Topical Hemostat Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom

13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.2. Market Share Analysis, By Key Player
13.3. Competitive Scenario Analysis, By Key Player
13.3.1. Merger & Acquisition
13.3.1.1. Hemostasis Closes Acquisition of Fiagon Medical Technologies
13.3.2. New Product Launch & Enhancement
13.3.2.1. Ethicon Introduces ETHIZIA Hemostatic Sealing Patch, Clinically Proven to Stop Disruptive Bleeding
13.3.3. Award, Recognition, & Expansion
13.3.3.1. Medcura Receives Breakthrough Device Designation for its LifeGel Absorbable Surgical Hemostat

14. Competitive Portfolio
14.1. Key Company Profiles
14.1.1. Aegis Lifesciences Private Limited
14.1.2. Axio Biosolutions Pvt Ltd
14.1.3. B.Braun Melsungen AG
14.1.4. Baxter International, Inc.
14.1.5. Becton, Dickinson and Company
14.1.6. Betatech Medical
14.1.7. BioCer Entwicklungs-GmbH
14.1.8. Bristol-Myers Squibb Company
14.1.9. Dilon Technologies Inc
14.1.10. GELITA MEDICAL GmbH
14.1.11. Hemostasis, LLC
14.1.12. Integra LifeSciences Corporation
14.1.13. Johnson & Johnson Services, Inc.
14.1.14. Marine Polymer Technologies, Inc.
14.1.15. Medline Industries, LP
14.1.16. Medtrade Products Ltd
14.1.17. Medtronic PLC
14.1.18. Meril Life Sciences Pvt. Ltd
14.1.19. Pfizer Inc.
14.1.20. Southmedic Inc.
14.1.21. Stryker Corporation
14.1.22. SYMATESE SAS
14.1.23. Takeda Pharmaceutical Company Limited
14.1.24. Teleflex Incorporated
14.1.25. Zeria Pharmaceutical Co., Ltd.
14.2. Key Product Portfolio

15. Appendix
15.1. Discussion Guide
15.2. License & Pricing



List of Figures

FIGURE 1. TOPICAL HEMOSTAT MARKET RESEARCH PROCESS
FIGURE 2. TOPICAL HEMOSTAT MARKET SIZE, 2023 VS 2030
FIGURE 3. TOPICAL HEMOSTAT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. TOPICAL HEMOSTAT MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. TOPICAL HEMOSTAT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. TOPICAL HEMOSTAT MARKET DYNAMICS
FIGURE 7. TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 8. TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2023 VS 2030 (%)
FIGURE 10. TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 12. TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
FIGURE 14. TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS TOPICAL HEMOSTAT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. AMERICAS TOPICAL HEMOSTAT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES TOPICAL HEMOSTAT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 18. UNITED STATES TOPICAL HEMOSTAT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC TOPICAL HEMOSTAT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC TOPICAL HEMOSTAT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. TOPICAL HEMOSTAT MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 24. TOPICAL HEMOSTAT MARKET SHARE, BY KEY PLAYER, 2023

List of Tables

TABLE 1. TOPICAL HEMOSTAT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018–2023
TABLE 3. TOPICAL HEMOSTAT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 6. TOPICAL HEMOSTAT MARKET SIZE, BY COLLAGEN-BASED TOPICAL HEMOSTATS, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. TOPICAL HEMOSTAT MARKET SIZE, BY COMBINATION TOPICAL HEMOSTATS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. TOPICAL HEMOSTAT MARKET SIZE, BY GELATIN-BASED TOPICAL HEMOSTATS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. TOPICAL HEMOSTAT MARKET SIZE, BY OXIDIZED REGENERATED CELLULOSE-BASED TOPICAL HEMOSTATS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. TOPICAL HEMOSTAT MARKET SIZE, BY THROMBIN-BASED TOPICAL HEMOSTATS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 12. TOPICAL HEMOSTAT MARKET SIZE, BY MATRIX & GEL HEMOSTATS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. TOPICAL HEMOSTAT MARKET SIZE, BY POWDER HEMOSTATS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. TOPICAL HEMOSTAT MARKET SIZE, BY SHEET & PAD HEMOSTATS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. TOPICAL HEMOSTAT MARKET SIZE, BY SPONGE HEMOSTATS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 17. TOPICAL HEMOSTAT MARKET SIZE, BY CARDIOVASCULAR SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. TOPICAL HEMOSTAT MARKET SIZE, BY GENERAL SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. TOPICAL HEMOSTAT MARKET SIZE, BY LIVER & SPLEEN LACERATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. TOPICAL HEMOSTAT MARKET SIZE, BY ORTHOPEDIC SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. TOPICAL HEMOSTAT MARKET SIZE, BY RECONSTRUCTIVE SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 23. TOPICAL HEMOSTAT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. TOPICAL HEMOSTAT MARKET SIZE, BY NURSING HOMES, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. TOPICAL HEMOSTAT MARKET SIZE, BY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. AMERICAS TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 27. AMERICAS TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 28. AMERICAS TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 29. AMERICAS TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 30. AMERICAS TOPICAL HEMOSTAT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 31. ARGENTINA TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 32. ARGENTINA TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 33. ARGENTINA TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 34. ARGENTINA TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 35. BRAZIL TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 36. BRAZIL TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 37. BRAZIL TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 38. BRAZIL TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 39. CANADA TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 40. CANADA TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 41. CANADA TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 42. CANADA TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 43. MEXICO TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 44. MEXICO TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 45. MEXICO TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 46. MEXICO TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 47. UNITED STATES TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 48. UNITED STATES TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 49. UNITED STATES TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 50. UNITED STATES TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 51. UNITED STATES TOPICAL HEMOSTAT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 52. ASIA-PACIFIC TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 53. ASIA-PACIFIC TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 54. ASIA-PACIFIC TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 55. ASIA-PACIFIC TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 56. ASIA-PACIFIC TOPICAL HEMOSTAT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 57. AUSTRALIA TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 58. AUSTRALIA TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 59. AUSTRALIA TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 60. AUSTRALIA TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 61. CHINA TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 62. CHINA TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 63. CHINA TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 64. CHINA TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 65. INDIA TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 66. INDIA TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 67. INDIA TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 68. INDIA TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 69. INDONESIA TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 70. INDONESIA TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 71. INDONESIA TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 72. INDONESIA TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 73. JAPAN TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 74. JAPAN TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 75. JAPAN TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 76. JAPAN TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 77. MALAYSIA TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 78. MALAYSIA TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 79. MALAYSIA TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 80. MALAYSIA TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 81. PHILIPPINES TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 82. PHILIPPINES TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 83. PHILIPPINES TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 84. PHILIPPINES TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 85. SINGAPORE TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 86. SINGAPORE TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 87. SINGAPORE TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 88. SINGAPORE TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 89. SOUTH KOREA TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 90. SOUTH KOREA TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 91. SOUTH KOREA TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 92. SOUTH KOREA TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 93. TAIWAN TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 94. TAIWAN TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 95. TAIWAN TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 96. TAIWAN TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 97. THAILAND TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 98. THAILAND TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 99. THAILAND TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 100. THAILAND TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 101. VIETNAM TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 102. VIETNAM TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 103. VIETNAM TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 104. VIETNAM TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 105. EUROPE, MIDDLE EAST & AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 106. EUROPE, MIDDLE EAST & AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 107. EUROPE, MIDDLE EAST & AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 108. EUROPE, MIDDLE EAST & AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 109. EUROPE, MIDDLE EAST & AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 110. DENMARK TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 111. DENMARK TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 112. DENMARK TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 113. DENMARK TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 114. EGYPT TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 115. EGYPT TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 116. EGYPT TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 117. EGYPT TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 118. FINLAND TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 119. FINLAND TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 120. FINLAND TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 121. FINLAND TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 122. FRANCE TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 123. FRANCE TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 124. FRANCE TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 125. FRANCE TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 126. GERMANY TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 127. GERMANY TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 128. GERMANY TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 129. GERMANY TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 130. ISRAEL TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 131. ISRAEL TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 132. ISRAEL TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 133. ISRAEL TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 134. ITALY TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 135. ITALY TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 136. ITALY TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 137. ITALY TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 138. NETHERLANDS TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 139. NETHERLANDS TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 140. NETHERLANDS TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 141. NETHERLANDS TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 142. NIGERIA TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 143. NIGERIA TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 144. NIGERIA TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 145. NIGERIA TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 146. NORWAY TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 147. NORWAY TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 148. NORWAY TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 149. NORWAY TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 150. POLAND TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 151. POLAND TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 152. POLAND TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 153. POLAND TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 154. QATAR TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 155. QATAR TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 156. QATAR TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 157. QATAR TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 158. RUSSIA TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 159. RUSSIA TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 160. RUSSIA TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 161. RUSSIA TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 162. SAUDI ARABIA TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 163. SAUDI ARABIA TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 164. SAUDI ARABIA TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 165. SAUDI ARABIA TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 166. SOUTH AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 167. SOUTH AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 168. SOUTH AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 169. SOUTH AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 170. SPAIN TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 171. SPAIN TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 172. SPAIN TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 173. SPAIN TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 174. SWEDEN TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 175. SWEDEN TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 176. SWEDEN TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 177. SWEDEN TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 178. SWITZERLAND TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 179. SWITZERLAND TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 180. SWITZERLAND TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 181. SWITZERLAND TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 182. TURKEY TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 183. TURKEY TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 184. TURKEY TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 185. TURKEY TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 186. UNITED ARAB EMIRATES TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 187. UNITED ARAB EMIRATES TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 188. UNITED ARAB EMIRATES TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 189. UNITED ARAB EMIRATES TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 190. UNITED KINGDOM TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 191. UNITED KINGDOM TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 192. UNITED KINGDOM TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 193. UNITED KINGDOM TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 194. TOPICAL HEMOSTAT MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 195. TOPICAL HEMOSTAT MARKET SHARE, BY KEY PLAYER, 2023
TABLE 196. TOPICAL HEMOSTAT MARKET LICENSE & PRICING